Search company, investor...

Total Raised

$971.14M

Investors Count

21

Deal Terms

4

Investments

2

Funding, Valuation & Revenue

8 Fundings

Miaoshou has raised $971.14M over 8 rounds.

Miaoshou's latest funding round was a Series F for $231.93M on August 3, 2021.

Miaoshou's valuation in June 2020 was $1,000M.

Miaoshou's latest post-money valuation is from August 2021.

Sign up for a free demo to see Miaoshou's valuations in August 2021, June 2019 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/3/2021

Series F

$231.93M

$XXM

0

FY undefined

8

2/9/2021

Series E

$XXM

$XXM

0

FY undefined

10

6/15/2020

Series D

$XXM

$1,000M

0

FY undefined

10

6/27/2019

Series C - III

$XXM

$XXM

0

FY undefined

10

1/7/2019

Series C - II

$XXM

$XXM

0

FY undefined

10

Date

8/3/2021

2/9/2021

6/15/2020

6/27/2019

1/7/2019

Round

Series F

Series E

Series D

Series C - III

Series C - II

Amount

$231.93M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$1,000M

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

8

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Miaoshou Deal Terms

4 Deal Terms

Miaoshou's deal structure is available for 4 funding rounds, including their Series F from August 03, 2021.

Round

Series F

Series D

Series C - III

Series C

Funding Date

$XXM

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series F

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series C - III

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Miaoshou Investors

21 Investors

Miaoshou has 21 investors. HongShan invested in Miaoshou's Series F funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/1/2015

8/3/2021

6
Series A, Series C (2018), Series C - II (2019), Series D (2020), Series E (2021), Series F (2021)

Venture Capital

China

6/15/2020

8/3/2021

2
Series D, Series F (2021)

Venture Capital

China

2/9/2021

8/3/2021

2
Series E, Series F (2021)

Venture Capital

New York

00/00/0000

00/00/0000

Index Capital

Subscribe to see more

Investment Bank

China

00/00/0000

00/00/0000

Kunling Capital

Subscribe to see more

Private Equity

China

First funding

8/1/2015

6/15/2020

2/9/2021

00/00/0000

00/00/0000

Last Funding

8/3/2021

8/3/2021

8/3/2021

00/00/0000

00/00/0000

Investor

Index Capital

Kunling Capital

Rounds

6
Series A, Series C (2018), Series C - II (2019), Series D (2020), Series E (2021), Series F (2021)
2
Series D, Series F (2021)
2
Series E, Series F (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Venture Capital

Investment Bank

Private Equity

Location

China

China

New York

China

China

Miaoshou Acquisitions

1 Acquisition

Miaoshou acquired 1 company. Their latest acquisition was MediCool on January 18, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/18/2021

$XXM

Corporate Majority

1

Date

1/18/2021

Investment Stage

Companies

Valuation

$XXM

Total Funding

Note

Corporate Majority

Sources

1

Miaoshou Investments

2 Investments

Miaoshou has made 2 investments. Their latest investment was in Yaobangshou as part of their Seed on September 09, 2020.

CBI Logo

Miaoshou Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/9/2020

Seed

Yaobangshou

Yes

Undisclosed Investors

5

1/25/2019

Series A

Subscribe to see more

Subscribe to see more

10

Date

9/9/2020

1/25/2019

Round

Seed

Series A

Company

Yaobangshou

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Co-Investors

Undisclosed Investors

Sources

5

10

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.